What's Behind Invitae's Q3 Earnings Beat
What a year it's been for Invitae (NYSE: NVTA). Its shares have skyrocketed well over 180% year to date thanks mainly to its big acquisition of leading genomics analysis company ArcherDX.
Invitae announced its third-quarter results after the market closed on Thursday. Did the medical genetics company give investors more reasons to cheer? Here are the highlights from the company's Q3 update.
Image Source: Getty Images.
Source Fool.com
